CANNOT BUY ONLINE

Maybe that is because there is not much to say at this stage?! Very slow progress with this company but at least it is progress. They have a solid core business but as it is a Biotech company it is going to be looked at with justified trepidation until it has earned a 'must have this technology' tag. The indications are that the tag is becoming overdue, though it does appear that some of their customers have already figured that out! Angel are going to be around for a long time I think. I have been tempted to dump my relatively small holding on many occasions but there is just something that keeps me hanging on. The next update has to be encouraging, if not............???

I have traded these many times in the past and made money on them each time, but am ready to hold a bigger stake because i have a confidence in the company and the sp so far hasn't let us down. The tie up with RENE is good but will be a long haul, saying that, they have many other connections to keep them busy.

Yes, plenty to be getting on with; a few ups and downs for the sp in the meantime no doubt!

http://www.express.co.uk/money/view/225937/Small-companies-roundup-Angel-Biotech-up-on-deal-rumours

Very interesting this one.....could go ballistic on good news....really could...so snapped up a few....

Bought some more today......beginning to look good here.

this from daily express today

Angel Biotechnology eased 0.008p to 0.377p despite speculation it was close to securing a multi-million-pound manufacturing contract over several years with a Russian pharma company

Read more: http://www.express.co.uk/posts/view/226438/Small-companies-roundup-21st-Century-Technology-up-on-Sweden-dealSmall-companies-roundup-21st-Century-Technology-up-on-Sweden-deal#ixzz1CkDt4frZ

Great news can't wait to see it happen........ and the sp............watch this thread lol

Courtesy of the Voids news paper tips, mentioned twice.
Share Tips of the Week
Buy - RBS
Buy - Angel Biotechnology

Lets hope it all happens...and very soon too!

Shares Magazine

Risk-tolerant investors should look to buy Angel Biotechnology ahead of a maiden pre-tax profit announcement for the full year. In addition, the shares should receive a boost from news of further contract wins from pharmaceutical and biotech firms in need of access to Angel's innovative technology. Angel specialises in producing advanced biologics, such as stem cells and cellular vaccines, for clients under contract. House broker Matrix say: 'From 2012 we expect strong sustainable profitability for the business with excellent cash generation.' Buy.

this is forming a solid base to launch from...just need the good news releases to be issued soon and whooosh! we're away...(imho of course!)

The drop to low thirtys didn't last long, (long enough for me to buy) and has now steadied around forty just waiting to jump past 50 and on .... gl all.,.

Super rise...33%...wow...!...

Still 18% up....like wise wow.,.

Nice!

Are you ready for the rocket ride........here we go!!

More and more promising......

Fizz, fizz, fizzle, thfffptt. Oh, come on rocket, get a move on!!

ok maybe not but from 45 to 61 first thing, thought there might be a 70 + init....

Patience required BB. Or in ABH's case, patients, loads of them requiring stuff made by them! :o)